# Candel Therapeutics, Inc. (CADL)

Candel Therapeutics (CADL) sees significant social media buzz around upcoming clinical trial results, with mentions up 233% and social dominance soaring 400% week-over-week. Investors are closely watching for positive catalysts, driving increased engagement and creator activity.

### About Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is a biotechnology company focused on developing viral immunotherapies.  
Candel Therapeutics, Inc. uses the ticker $CADL for trading. Listed in the [Stocks](/list/stocks) category.

### Insights
- Candel Therapeutics, Inc. (CADL) mentions hit [---] which is 246% higher than it's daily average.
- Candel Therapeutics, Inc. (CADL) creators hit [--] which is 156% higher than it's daily average.
- Candel Therapeutics, Inc. (CADL) social dominance is up 442.86% from the previous week.
- Candel Therapeutics, Inc. (CADL) Galaxy Score™ is up 137.5% from the previous month.
- Candel Therapeutics, Inc. (CADL) creators is up 28.97% from the previous week.
- Candel Therapeutics, Inc. (CADL) engagements is up 44.29% from the previous week.
- Candel Therapeutics, Inc. (CADL) mentions is up 32.66% from the previous week.
- Candel Therapeutics, Inc. (CADL) posts created is up 306.25% from the previous week.
- Candel Therapeutics, Inc. Galaxy Score™ hit a 52-Week high of [--] for the hour

### Price: $5.70
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/close.tsv)  
The price action is likely driven by anticipation of positive news from upcoming clinical trial results and PDUFA dates, as indicated by social posts mentioning bounces and potential price increases.  

24-Hour: 1.43%
7-Day: 2.03%
30-Day: -11.25%

1-Year High: $7 on 2025-07-25  
1-Year Low: $4.40 on 2025-11-19  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/alt_rank.tsv)  
Candel Therapeutics, Inc. (CADL) is currently AltRank #1,236 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +380  
1-Year High: [-----] on 2026-02-09  
1-Year Low: [---] on 2026-01-24  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +9  
[--] Month: [--] +22  
[--] Months: [--] +14  
[--] Year: [--] [---]  
1-Year High: [--] on 2026-02-02  
1-Year Low: [--] on 2026-02-05  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [------] +44%  
[--] Month: [-------] -5.60%  
[--] Months: [-------] -46%  
[--] Year: [---------] -62%  
1-Year High: [------] on 2025-07-09  
1-Year Low: [--] on 2025-04-19  

Engagements by network (24h):
News: [--]
X: [-----]
Reddit: [--]
YouTube: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [--]  
[--] Week: [---] +33%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-11-09  

Mentions by network (24h):
News: [--]
X: [---]
Reddit: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Candel Therapeutics, Inc. (CADL) in the last [--] hours which is up 22% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] +29%  
1-Year High: [---] on 2025-06-29  
1-Year Low: [--] on 2025-11-09  

The most influential creators that mention Candel Therapeutics, Inc. in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [-----]       |
| [@CandelTx](/creator/twitter/CandelTx)               | [--]    | [---]       | [--]    | [---]         |
| [@austinvrabel](/creator/twitter/austinvrabel)       | [--]    | [---]       | [--]     | [--]          |
| [@_le_Lounge](/creator/twitter/_le_Lounge)           | [--]    | [-----]     | [--]     | [--]          |
| [@Stock_Marketr11](/creator/twitter/Stock_Marketr11) | [--]    | [---]       | [--]     | [--]          |
| [@oliviatrading_6](/creator/twitter/oliviatrading_6) | [--]    | [---]       | [--]     | [--]          |
| [@Muralidharan125](/creator/twitter/Muralidharan125) | [--]    | [---]       | [--]     | [--]          |
| [@Tompson98315](/creator/twitter/Tompson98315)       | [--]    | [--]         | [--]     | [--]          |
| [@toptrader_usa](/creator/twitter/toptrader_usa)     | [--]    | [--]        | [--]     | [--]          |
| [@TradeM470](/creator/twitter/TradeM470)             | [--]   | [---]       | [--]     | [--]          |

[View More](/list/creators/$cadl/100)
  
  
### Sentiment: 53%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/sentiment.tsv)  
Current Value: 53%  
Daily Average: 85%  
[--] Week: 50% -50%  
[--] Month: 46% -54%  
[--] Months: 46% -16%  
[--] Year: 46% -54%  
1-Year High: 100% on 2025-02-18  
1-Year Low: 9% on 2025-11-16  

Most Supportive Themes:
- Biotech Stock Catalyst Watchlist: (67%) Focuses on upcoming clinical trial readouts for various biotechnology companies.
- Stock Bounce Potential: (33%) Highlights potential stock price increases based on market movements and specific company news.
  
Most Critical Themes:
  
  
  
### Social Dominance: 0.011%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/social_dominance.tsv)  
Current Value: 0.011%  
Daily Average: 0.00663%  
[--] Week: 0.0038% +0.0031%  
[--] Month: 0.011% +0.0082%  
[--] Months: 0.011% +0.0045%  
[--] Year: 0.011% -0.0005000000000000004%  
1-Year High: 0.036% on 2025-06-29  
1-Year Low: 0.0004% on 2025-11-09  
  
  
### Market Dominance: 0.00035313523701191083%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/market_dominance.tsv)  
Current Value: 0.00035313523701191083%  
Daily Average: 0%  
1-Year High: 0.015% on 2026-02-06  
1-Year Low: 0.00035% on 2026-02-15  
  
  
### Market Cap: $311,822,361
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$cadl/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$cadl/time-series/market_cap.tsv)  
Current Value: $311,822,361  
Daily Average: $326,612,610  
[--] Week: $311,822,361 -4.50%  
[--] Month: $311,822,361 -11%  
1-Year High: $351,349,139 on 2026-01-16  
1-Year Low: $290,412,023 on 2026-02-05  

### Top Candel Therapeutics, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $MLTX Phase [--] $BFRI Phase [--] $BCDA Phase [--] $KPTI Phase [--] $IOVA Phase [--] $XENE Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA"  
[X Link](https://x.com/BiopharmIQ/status/2020573160345940394) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-08T18:59Z 28.9K followers, [----] engagements


"Biotech Stock Catalyst Watchlist Ph2 & Ph3 readouts in Q1 [----] 📈 $KOD Phase 2b $MDNAF Phase 2b $GOSS Phase [--] $BFRI Phase [--] $BFRI Phase [--] $KPTI Phase [--] $IOVA Phase [--] $AGIO Phase 2b $AVBP Phase [--] $ATAI Phase [--] $MLYS Phase [--] $TARA Phase [--] $CADL Phase 2a $ANRO Phase [--] $IMMP Phase [--] $PEPG Phase [--] $TBPH Phase [--] $CLDX Phase [--] $NVCR Phase [--] $VRDN Phase [--] $CMPX Phase 2/3 $ZBIO Phase [--] $IDYA Phase 2/3 $VXRT Phase 2b $OCUL Phase [--] $LSTA Phase 2b $PCSA Phase [--] $MLTX Phase [--] $OCGN Phase [--] $APGE Phase [--] $CMPS Phase [--] $MBRX Phase [--] $KOD Phase [--] $NKTR Phase 2b $ALZN Phase [--] $HELP Phase [--] $PVLA Phase [--] $ARQT"  
[X Link](https://x.com/BiopharmIQ/status/2018051066605220000) [@BiopharmIQ](/creator/x/BiopharmIQ) 2026-02-01T19:57Z 28.9K followers, 114.2K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing